A Study to Learn About the Study Medicine Called PF-08653944 Taken Once-Weekly Compared to Placebo in Chinese Adults With Overweight or Obesity
NCT07792954
·
clinicaltrials.gov ↗
PHASE3
Phase
NOT_YET_RECRUITING
Status
300
Enrollment
INDUSTRY
Sponsor class
Conditions
Obesity
Overweight
Interventions
DRUG:
Berobenatide
OTHER:
Placebo
Sponsor
Pfizer